Posts found in:
Michael Wysolmerski
KO Client Sydnexis Completes $45M Series B Financing
- KO Firm
- |
- August 25, 2021
Sydnexis, Inc., a clinical stage biopharmaceutical company, has completed a $45 million Series B financing led by Visionary Ventures, Blue Stem Capital, and SC Master Fund. The KO team, led by partners Kevin Gibson and Brad Schoenfeld, represented Sydnexis. The company sees progressive myopia (nearsightedness) in children as a “significant…
- 1
- 2
